Results 91 to 100 of about 12,754 (124)

Comprehensive bioinformatics analysis of co-mutation of <i>FLG2</i> and <i>TP53</i> reveals prognostic effect and influences on the immune infiltration in ovarian serous cystadenocarcinoma. [PDF]

Transl Cancer Res
Li M, Han D, Jin H.
europepmc   +1 more source

Comprehensive analysis of the expression of sodium/potassium-ATPase α subunits and prognosis of ovarian serous cystadenocarcinoma. [PDF]

Cancer Cell Int, 2020
Huang W, Zhang Y, Xu Y, Yang S, Li B, Huang L, Lou G.   +6 more
europepmc   +1 more source

ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1. [PDF]

J Transl Med
Li YK, Gao AB, Zeng T, Liu D, Zhang QF, Ran XM, Tang ZZ, Li Y, Liu J, Zhang T, Shi GQ, Zhou WC, Zou WD, Peng J, Zhang J, Li H, Zou J.   +16 more
europepmc   +1 more source

Identification of a 3-mRNA signature as a novel potential prognostic biomarker in patients with ovarian serous cystadenocarcinoma in G2 and G3. [PDF]

Oncol Lett, 2019
Zhou J, Yi Y, Wang C, Su C, Luo Y.
europepmc   +1 more source

LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway. [PDF]

Cancer Cell Int, 2019
Cui R, Cao G, Bai H, Zhang Z.
europepmc   +1 more source

Bilateral Breast and Axillary Lymph Nodes Metastases of an Ovarian Serous Cystadenocarcinoma. [PDF]

Indian J Surg Oncol, 2018
Mir M, Lashkari M, Latif A, Mir A.
europepmc   +1 more source

A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma. [PDF]

Clin Epigenetics, 2018
Guo W, Zhu L, Yu M, Zhu R, Chen Q, Wang Q.   +5 more
europepmc   +1 more source

Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma. [PDF]

Oncol Rep, 2017
Cho SY, Kim K, Park MS, Jang MY, Choi YH, Han S, Shin HM, Chung C, Han HY, Yang JB, Ko YB, Yoo HJ.   +11 more
europepmc   +1 more source

Two protein-coding genes act as a novel clinical signature to predict prognosis in patients with ovarian serous cystadenocarcinoma. [PDF]

Oncol Lett, 2018
Zhang J, Xu M, Gao H, Guo JC, Guo YL, Zou M, Wu XF.   +6 more
europepmc   +1 more source

A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma. [PDF]

Biomed Res Int, 2016
Liu LW, Zhang Q, Guo W, Qian K, Wang Q, Wang Q.   +5 more
europepmc   +1 more source